对抗幽门螺杆菌:纳米材料的焦点。

IF 4.3 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Helicobacter Pub Date : 2024-12-26 DOI:10.1111/hel.70004
Xuanping Wang, Xihui Felicia Chan, Yuyo Go, Yishen Wang, Tingyu Li, Gangshi Wang
{"title":"对抗幽门螺杆菌:纳米材料的焦点。","authors":"Xuanping Wang,&nbsp;Xihui Felicia Chan,&nbsp;Yuyo Go,&nbsp;Yishen Wang,&nbsp;Tingyu Li,&nbsp;Gangshi Wang","doi":"10.1111/hel.70004","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Developing effective non-antibiotic antimicrobial strategies is essential for combating global antibiotic resistance, including resistance stemming from <i>Helicobacter pylori</i> (<i>H. pylori</i>) treatment. Nanomaterials offer a promising and innovative approach for non-antibiotic anti-<i>H. pylori</i> treatment strategies. This review highlights the progress made in the use of metallic and nonmetallic nanoparticles, as well as nanozymes, to directly inhibit <i>H. pylori</i> growth. Moreover, we summarize advances made in the direct targeting of <i>H. pylori</i> by nanomaterials and the stimuli-responsive release of nanoparticles in the stomach. Additionally, we explore the recent advancements in multifunctional nanoplatforms that integrate physical methods, such as light, heat, ultrasound, and magnetism, with nanomaterials to synergistically treat <i>H. pylori</i> infections. Finally, we briefly address the existing challenges and future directions in this field. In summary, we highlight that with ongoing research, nanomaterials may serve as a promising treatment strategy for <i>H. pylori</i> eradication.</p>\n </div>","PeriodicalId":13223,"journal":{"name":"Helicobacter","volume":"29 6","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combatting Helicobacter pylori: A Focus on Nanomaterials\",\"authors\":\"Xuanping Wang,&nbsp;Xihui Felicia Chan,&nbsp;Yuyo Go,&nbsp;Yishen Wang,&nbsp;Tingyu Li,&nbsp;Gangshi Wang\",\"doi\":\"10.1111/hel.70004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>Developing effective non-antibiotic antimicrobial strategies is essential for combating global antibiotic resistance, including resistance stemming from <i>Helicobacter pylori</i> (<i>H. pylori</i>) treatment. Nanomaterials offer a promising and innovative approach for non-antibiotic anti-<i>H. pylori</i> treatment strategies. This review highlights the progress made in the use of metallic and nonmetallic nanoparticles, as well as nanozymes, to directly inhibit <i>H. pylori</i> growth. Moreover, we summarize advances made in the direct targeting of <i>H. pylori</i> by nanomaterials and the stimuli-responsive release of nanoparticles in the stomach. Additionally, we explore the recent advancements in multifunctional nanoplatforms that integrate physical methods, such as light, heat, ultrasound, and magnetism, with nanomaterials to synergistically treat <i>H. pylori</i> infections. Finally, we briefly address the existing challenges and future directions in this field. In summary, we highlight that with ongoing research, nanomaterials may serve as a promising treatment strategy for <i>H. pylori</i> eradication.</p>\\n </div>\",\"PeriodicalId\":13223,\"journal\":{\"name\":\"Helicobacter\",\"volume\":\"29 6\",\"pages\":\"\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Helicobacter\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/hel.70004\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Helicobacter","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hel.70004","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

制定有效的非抗生素抗微生物策略对于对抗全球抗生素耐药性至关重要,包括幽门螺杆菌治疗引起的耐药性。纳米材料为非抗生素抗h提供了一种有前途的创新方法。幽门螺杆菌治疗策略。本文综述了利用金属和非金属纳米颗粒以及纳米酶直接抑制幽门螺杆菌生长的进展。此外,我们还总结了纳米材料直接靶向幽门螺杆菌和纳米颗粒在胃中的刺激反应释放方面的进展。此外,我们还探索了多功能纳米平台的最新进展,该平台将光、热、超声和磁性等物理方法与纳米材料结合起来,协同治疗幽门螺杆菌感染。最后,简要介绍了该领域存在的挑战和未来的发展方向。总之,我们强调,随着正在进行的研究,纳米材料可能作为一种有前途的治疗策略根除幽门螺杆菌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Combatting Helicobacter pylori: A Focus on Nanomaterials

Developing effective non-antibiotic antimicrobial strategies is essential for combating global antibiotic resistance, including resistance stemming from Helicobacter pylori (H. pylori) treatment. Nanomaterials offer a promising and innovative approach for non-antibiotic anti-H. pylori treatment strategies. This review highlights the progress made in the use of metallic and nonmetallic nanoparticles, as well as nanozymes, to directly inhibit H. pylori growth. Moreover, we summarize advances made in the direct targeting of H. pylori by nanomaterials and the stimuli-responsive release of nanoparticles in the stomach. Additionally, we explore the recent advancements in multifunctional nanoplatforms that integrate physical methods, such as light, heat, ultrasound, and magnetism, with nanomaterials to synergistically treat H. pylori infections. Finally, we briefly address the existing challenges and future directions in this field. In summary, we highlight that with ongoing research, nanomaterials may serve as a promising treatment strategy for H. pylori eradication.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Helicobacter
Helicobacter 医学-微生物学
CiteScore
8.40
自引率
9.10%
发文量
76
审稿时长
2 months
期刊介绍: Helicobacter is edited by Professor David Y Graham. The editorial and peer review process is an independent process. Whenever there is a conflict of interest, the editor and editorial board will declare their interests and affiliations. Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. As new helicobacter species are now regularly being discovered, Helicobacter covers the entire range of helicobacter research, increasing communication among the fields of gastroenterology; microbiology; vaccine development; laboratory animal science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信